Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5633742 | 6361695 | F | 2 | 5633742-0 | 20070618 | 20080129 | 20080219 | EXP | VNL_00627_2007 | VERNALIS PHARMACUETICALS, INC. | M | N | 20080212 | MD | UNITED KINGDOM |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5633742 | 1009545618 | PS | APO-GO (APO-GO PFS 5 MG/ML SOLUTION FOR INFUSION IN PRE-FILLED SYRINGE | 2 | SUBCUTANEOUS | (5.5 MG PER HOUR FOR 5 YEARS 5 MONTHS FOR 12 HOURS PER DAY SUBCUTANEOUS) | D | D | 21264 | ||
| 5633742 | 1009587409 | C | MADOPAR /00349201/ | 2 | |||||||
| 5633742 | 1009587410 | C | RASAGILINE | 2 | |||||||
| 5633742 | 1009587411 | C | FINASTERIDE | 1 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 5633742 | 1009545618 | PARKINSON'S DISEASE |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 5633742 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 5633742 | COOMBS POSITIVE HAEMOLYTIC ANAEMIA |
| 5633742 | FATIGUE |
| 5633742 | INFUSION RELATED REACTION |
| 5633742 | PLATELET COUNT INCREASED |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 5633742 | FGN |
| 5633742 | HP |
| 5633742 | OTH |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 5633742 | 1009545618 | 20020201 |